相关实验视频

Updated: Jul 25, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

为老年人开发呼吸道同胞病毒候选疫苗

Jorge C G Blanco¹, Lori M Cullen², Arash Kamali¹

¹Sigmovir Biosystems Inc., Rockville, MD 20850, USA.

|June 28, 2023

概括

病毒样颗粒 (VLP) 疫苗在年轻和老年人群中有效地刺激了对呼吸道同胞病毒 (RSV) 的保护性免疫反应. 之前的RSV感染并没有阻碍VLP疫苗在老年或年轻动物中的有效性.

科学领域:

免疫学免疫学免疫学
病毒学病毒学
疫苗学疫苗学疫苗学

背景情况:

呼吸道同胞性病毒 (RSV) 对老年人构成重大健康风险,终身感染提供有限的保护.
了解与年龄相关的免疫变化 (免疫衰老) 和先前感染如何影响疫苗反应对于开发有效的老年人疫苗至关重要.

研究的目的:

为了评估病毒样颗粒 (VLP) 疫苗在老年人与年轻的棉花大鼠之前接触RSV疫苗的疗效.
评估免疫衰老和先前感染对RSV VLP免疫接种免疫反应的影响.

主要方法:

在年轻和老年人VLP免疫接种后,免疫反应 (抗pre-F IgG,抗G IgG,中和抗体标位) 的比较,RSV经验丰富的棉鼠.
免疫接种后对RSV挑战保护的评估.

主要成果:

在RSV VLP免疫接种中,在年轻和年老的棉花大鼠中,抗F IgG,抗G IgG和中和抗体的水平相似.
这两个年龄组在VLP接种疫苗后,对RSV挑战表现出类似的保护.
之前的RSV感染并没有降低任何年龄组的疫苗诱导的免疫反应或保护.

结论:

含有F和G蛋白质的病毒样粒子 (VLP) 疫苗在激活年轻人和老年人的保护性免疫反应方面同样有效.
RSV VLP疫苗可以有效地利用前感染的现有免疫记忆在两个年龄组,表明作为老年人有效的疫苗的潜力.

关键词:

免疫力是一种免疫力.呼吸道同胞性病毒疫苗疫苗疫苗疫苗类似病毒的颗粒.

更多相关视频

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

相关概念视频

Common Respiratory Disorders

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Acute Respiratory Failure-III

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...

Acute Respiratory Failure-I

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...